Anti-Hepatitis G Virus [Polyclonal]
- -
- -
Antibody DetailsProduct DetailsReactivity Species Hepatitis G Virus Host Species Rabbit Immunogen Peptide corresponding to amino acids 2268-2276 of the NS5 non- structural polyprotein of Hepatitis G Virus (HGV). Product Concentration Lot Specific Formulation Phosphate-buffered saline (PBS), pH 7.4, containing 0.02% sodium azide State of Matter Liquid Product Preparation Purified by immunoaffinity chromatography Storage and Handling For long-term storage, we recommend aliquoting the undiluted antibody into smaller working volumes (10-30 µL/vial, depending on your usage) immediately upon arrival. Store these aliquots at -20°C or -80°C. Keep a separate working aliquot at 4°C for short-term use. To maintain product integrity, avoid repeated freeze/thaw cycles. This antibody is stable for at least one year when stored as recommended. Country of Origin USA Shipping Next Day 2-8°C Applications and Recommended Usage? Quality Tested by Leinco Immunoblotting: use at 1:500-1:1,000. Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. DescriptionSpecificity This Rabbit Polyclonal Antibody is specific to the NS5 polyprotein of HGV, also known as GBV-C/HBV (Hepatitis G Virus). Background Hepatitis G virus (HGV), also known as GB virus C (GBV-C), belongs to the GB virus group, which includes GBV-A, GBV-B, and GBV-C. HGV is a positive-sense, single-stranded RNA virus with a genome approximately 10 kilobases in length. Based on its genomic structure and organization, HGV is classified within the Flaviviridae family, yet it is genetically distinct from hepatitis C virus (HCV). Transmission of HGV primarily occurs through blood-to-blood contact, such as transfusion from HGV RNA–positive donors. Although infection may lead to mild elevations in liver enzymes, it is generally not associated with chronic liver disease or significant hepatic pathology. Despite its name, HGV is not clearly linked to hepatitis-related liver damage, and its clinical relevance continues to be explored, particularly in co-infections with HIV and HCV. Antigen DetailsResearch Area Infectious Disease References & CitationsTechnical Protocols |
